Final answer:
CRISPR technology is being trialed in China to target tumors by altering their genetic makeup, with the potential to transform cancer treatment.
Step-by-step explanation:
The trial in China using CRISPR technology for medical purposes is being conducted on tumors. This innovative approach involves manipulating the tumor's gene editing technologies, specifically the CRISPR/Cas9 system, to alter the DNA of cancerous cells. By applying CRISPR to excise and replace malfunctioning DNA sequences, researchers aim to correct the genetic errors at the root of cancer. The precision of CRISPR has revolutionized the prospects of gene therapy, particularly in oncology, with potential to treat the tumor by removing its cancerous properties and reintroducing the edited cells into the patient to combat the disease.